Is Pfizer publicly traded?
P fizer, the world’s largest drug company, is going to try its hand at picking biotech stocks. The New York pharma giant has set aside up to $500 million that it will invest in publicly traded...
Who owns shares of Pfizer?
Pfizer (NYSE: PFE) is owned by 64.95% institutional shareholders, 0.26% Pfizer insiders, and 34.79% retail investors. Vanguard Group Inc is the largest individual Pfizer shareholder, owning 459.94M shares representing 8.19% of the company.
Should I buy Pfizer Inc. (PFE)?
Pfizer Inc. (NYSE:PFE) released its full-year results, but the market seems to be already pricing-in a decline. Shares are down 4.4% to US$51.5 in the past week, and the stock is currently in the red. Markets are forward-looking, and the price decline ...
Why is Pfizer stock falling?
This article was first published on Simply Wall St News Pfizer Inc. (NYSE ... It is apparent that this could be partly the reason why the stock price started trending downwards.
See more
Is Pfizer Buy Sell or Hold?
Pfizer has received a consensus rating of Hold. The company's average rating score is 2.47, and is based on 9 buy ratings, 10 hold ratings, and no sell ratings.
How much does it cost to buy Pfizer stock?
2. Consider how Pfizer stock fits into your portfolioLearn MoreLearn MoreLearn MoreFees $0 per tradeFees $0 per trade for online U.S. stocks and ETFsFees $0 per tradeAccount minimum $0Account minimum $0Account minimum $03 more rows
Can I buy one share of Pfizer stock?
Place an Order for Pfizer Log on to your brokerage account and enter PFE—Pfizer's stock symbol—plus the number of shares you want to purchase. If your platform allows you to buy fractional shares, enter the dollar amount you want to invest in Pfizer.
How often does Pfizer pay dividends?
Pfizer (NYSE:PFE) pays quarterly dividends to shareholders. When is Pfizer's next dividend payment? Pfizer's next quarterly dividend payment of $0.40 per share will be made to shareholders on Friday, June 10, 2022.
When was the last time Pfizer stock split?
PFE's 6th split took place on November 17, 2020. This was a 1054 for 1000 split, meaning for each 1000 shares of PFE owned pre-split, the shareholder now owned 1054 shares.
Who is Pfizer merging with?
MylanPfizer has agreed to merge its off-patent drugs franchise, Upjohn, with Mylan, the companies said Monday. The deal would allow Pfizer and Mylan to combine two under-pressure businesses into a new giant with projected 2020 revenues of $19 billion to $20 billion.
Why is Pfizer stock so low?
Pfizer shares dropped sharply after the company's 2022 sales guidance appeared to fall short of expectations. The guidance that Pfizer PFE –0.15% (ticker: PFE) presented, however, doesn't take into account future sales of Pfizer's Covid-19 vaccine and antiviral, but only sales already made.
Is PFE in the Dow?
After Pfizer had been elected to replace another stock in the Dow Jones Industrial Average, the company said it was very pleased that it had been selected, as this is the best-known stock market barometer in the world.
Is Pfizer publicly traded?
Stock Listing The principal market for our Common Stock is the New York Stock Exchange (NYSE). Our stock is also traded on various United States regional stock exchanges.
What stock paid the highest dividend?
Most American dividend stocks pay investors a set amount each quarter, and the top ones increase their payouts over time, so investors can build an annuity-like cash stream....25 high-dividend stocks.SymbolCompany nameDividend yieldMOAltria Group Inc6.47%OKEONEOK Inc5.9%UVVUniversal Corp5.39%ALEALLETE Inc.4.38%21 more rows•May 2, 2022
Will Pfizer raise its dividend for 2022?
(NYSE: PFE) today announced that its board of directors declared a $0.40 second-quarter 2022 dividend on the company's common stock, payable June 10, 2022, to holders of the Common Stock of record at the close of business on May 13, 2022.
What stock pays the best dividend?
9 highest dividend-paying stocks in the S&P 500:Philip Morris International Inc. (PM)Vornado Realty Trust (VNO)Simon Property Group Inc. (SPG)International Business Machines Corp. (IBM)Oneok Inc. (OKE)Kinder Morgan Inc. (KMI)AT&T Inc. (T)Altria Group Inc. (MO)More items...
Is Pfizer stock a Buy, Sell or Hold?
Pfizer stock has received a consensus rating of hold. The average rating score is A2 and is based on 7 buy ratings, 31 hold ratings, and 0 sell rat...
What was the 52-week low for Pfizer stock?
The low in the last 52 weeks of Pfizer stock was 38.48. According to the current price, Pfizer is 141.76% away from the 52-week low.
What was the 52-week high for Pfizer stock?
The high in the last 52 weeks of Pfizer stock was 61.70. According to the current price, Pfizer is 88.41% away from the 52-week high.
What are analysts forecasts for Pfizer stock?
The 38 analysts offering price forecasts for Pfizer have a median target of 47.71, with a high estimate of 70.00 and a low estimate of 36.00. The m...
Is Pfizer a buy right now?
19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 10 hold ratings and...
Are investors shorting Pfizer?
Pfizer saw a decline in short interest in May. As of May 15th, there was short interest totaling 57,670,000 shares, a decline of 15.2% from the Apr...
When is Pfizer's next earnings date?
Pfizer is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022. View our earnings forecast for Pfizer .
How were Pfizer's earnings last quarter?
Pfizer Inc. (NYSE:PFE) issued its quarterly earnings data on Tuesday, May, 3rd. The biopharmaceutical company reported $1.62 earnings per share for...
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer declared a quarterly dividend on Thursday, April 28th. Shareholders of record on Friday, May 13th will be given a dividend of $0.40 per shar...
Is Pfizer a good dividend stock?
Pfizer pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.98%. Pfizer has been increasing its dividend for 12 conse...
What guidance has Pfizer issued on next quarter's earnings?
Pfizer updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $6.25-$6.45 for the period, compared to the...
What price target have analysts set for PFE?
19 equities research analysts have issued 12-month target prices for Pfizer's stock. Their forecasts range from $44.00 to $76.00. On average, they...
Who are Pfizer's key executives?
Pfizer's management team includes the following people: Dr. Albert Bourla D.V.M. , DVM, Ph.D., Chairman & CEO (Age 60, Pay $11.07M) Mr. Frank A....
What is Pfizer Inc?
What is Pfizer's business?
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
How long has Pfizer been increasing its dividend?
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
What is the dividend payout ratio of Pfizer?
Pfizer has been increasing its dividend for 12 years.
What is the PFE symbol?
Pfizer does not yet have a strong track record of dividend growth. The dividend payout ratio of Pfizer is 70.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Pfizer will have a dividend payout ratio of 47.42% next year.
How much of Pfizer is held by institutions?
Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."
What is the P/E ratio of Pfizer?
64.99% of the stock of Pfizer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
What is the consensus rating for Pfizer?
The P/E ratio of Pfizer is 14.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.25.
What is Pfizer's biopharmaceutical?
Pfizer has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 5 buy ratings, 8 hold ratings, and no sell ratings.
Pfizer (NYSE:PFE) Price Target and Consensus Rating
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide . It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Pfizer (NYSE:PFE) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
What is Pfizer's target price?
According to the issued ratings of 19 analysts in the last year, the consensus rating for Pfizer stock is Buy based on the current 9 hold ratings and 10 buy ratings for PFE. The average twelve-month price target for Pfizer is $58.39 with a high price target of $76.00 and a low price target of $44.00. Learn more on PFE's analyst rating history
What is Pfizer stock option?
Pfizer's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Pfizer Inc and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Pfizer depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Pfizer Inc including analysis of its current option contracts.
How is Pfizer target price determined?
Pfizer's stock options are financial instruments that give investors the right to buy or sell shares of Pfizer Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Pfizer stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Pfizer's stock price goes up or down, the stock options follow.
How are Pfizer's analyst recommendations determined?
Pfizer target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
What is max pain in stock options?
Pfizer's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Pfizer stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Pfizer's financials, market performance, and future outlook by experienced professionals. Pfizer's historical ratings below, therefore, can serve as a valuable tool for investors.
What is mean reversion in Pfizer?
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Pfizer close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
What is Pfizer value examination?
This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Why is Pfizer down?
Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price.
Why is Pfizer weighing down?
Another reason Pfizer has been down is that they've had some clinical setbacks. They really had high hopes for breast cancer drug Ibrance, and early breast cancer setting, and had a couple of clinical studies that didn't pan out so well, and so that's been another negative impact on the stock.
